According to the research report titled ‘GLOBAL Multiplex Assay Market 2021-2028’, available with MarketStudyReport, global multiplex assay market size is expected to increase at a healthy CAGR of 8.67% during the forecast timeframe of 2021-2028.
 

Surging acceptance of customized medications and rising preference of multiplex assays over conventional methods are augmenting the market growth. Besides, elevated functionality immunoassay in various government health agencies, as well as opportunities in emerging nations are likely to widen the worldwide multiplex assay industry growth in the ensuing years.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/4142970/
 

Coming to constraints, lack of experienced workforce and regulatory actions concerning environmental safety might impede market progression in the coming years, claims the study.
 

Based on type, the market is split into protein-based multiplex assay, nucleic-acid based multiplex assay, and others. In terms of application, clinical diagnostics, research and development, and companion diagnostics.
 

Considering technology, multiplex PCR and multiplex protein microarray are the key segments highlighted in the research document. Moving to industry verticals, the segmentation is comprised of research institutes, pharmaceutical & biotechnology companies, clinical laboratories, and hospitals.  
 

From regional perspective the worldwide multiplex assay market report covers North America (U.S., Canada), Europe (UK, Germany, Spain, France, Italy, Russia), Asia Pacific (Japan, China, South Korea, India, New Zealand, Australia), MEA (South Africa, Turkey, Saudi Arabia, UAE), and Latin America (Mexico and Brazil).
 

Asia-Pacific market is estimated to expand at a notable pace, primarily due to rising demand for healthcare facilities, as well as spike in the number of hospitals in emerging nations such as India and China. Aside from this, advancements in R&D infrastructure, increasing healthcare reforms and technology improvements are enhancing the growth prospects.
 

In terms of the competitive landscape, Olink Proteomics AB, Thermo Fisher Scientific Corp, Siemens Healthineers AG, ., F. Hoffmann-La Roche AG, Luminex Corp., Randox Laboratories Ltd., Abcam, Agilent Technologies Inc., Becton Dickinson and Co., Bio Techne Corp., Qiagen N.V., Merck Millipore, Illumina Inc., Meso Scale Diagnostics LLC, Seegene Inc., and Bio Rad Laboratories Inc. are the key players in multiplex assay industry.